Current Collaborations
Lipid mediators
LONDON![]() DeltaDot and Dr Cali Hyde in the Bioanalysis lab, at LBIC
Developing new assays for eicosanoid measurements ![]() Dr Ludo Pelligand
Developing new assays for eicosanoid measurements Prof Jane Mitchell, Imperial College London
Eicosanoids in vascular, respiratory and inflammatory health Dr Sue Barker, School of Pharmacy, UCL.
Therapeutic delivery of lipids |
London![]() Prof Derek Gilroy, UCL
Inflammatory resolution ![]() Prof Tim Warner, QMUL
Eicosanoid regulation and thrombosis, and beloved local figure ![]() Prof Magdi Yaqoob, Barts and the London
Epoxygenase function in Chronic Kidney Disease ![]() Dr Irilenia Nobeli, Birkbeck
Molecular modelling of lipid metabolising CYP enzymes Dr Jacques Behmoaras, Imperial College London
Epoxygenase function in obesity |
International![]() Prof Darryl Zeldin, NIEHS/ NIH, NC, USA
Epoxygenases in health and disease ![]() Prof Bruce Hammock, UC Davies, USA
Soluble epoxide hydrolase inhibitors as therapeutic tools for vascular, renal and inflammatory disorders Dr Aili Lazaar, GSK, King of Prussia, USA.
Soluble epoxide hydrolase inhibitors as therapeutic tools for inflammatory disorders.
Prof Nicole Wagner. University of Nice PPARb/d in angiogenesis Prof Byeong Jang, Keimyung University, Republic of Korea.
Marine products for cancer and metabolic diseases Prof Michael Murray, University of Sydney, Australia.
Epoxy-fatty acid analogues in health and disease |